Kinase inhibitors

Details for Australian Patent Application No. 2005210459 (hide)

Owner Eli Lilly and Company

Inventors De Dios, Alfonso; Selgas, Sheila Pleite; Kotiyan, Pramila; Hamdouchi, Chafiq Hamdouchi; Mader, Mary Margaret; Sanchez-Martinez, Concepcion; Jaramillo Aguado, Carlos; Bonjouklian, Rosanne; Del Prado, Miriam Filadelfa; Shih, Chuan

Agent Spruson & Ferguson

Pub. Number AU-B-2005210459

PCT Pub. Number WO2005/075478

Priority 60/540,830 30.01.04 US

Filing date 25 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 21 October 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

11 January 2007 Section 223 Application Allowed

  Eli Lilly And Company The time in which to enter the National Phase has been extended to 30 Sep 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

25 January 2007 PCT application entered the National Phase

  PCT publication WO2005/075478 Priority application(s): WO2005/075478

21 October 2010 Application Accepted

  Published as AU-B-2005210459

17 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210467-System and method for measuring electric current in a pipeline

2005210452-Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof